Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session



  • Crown ElectroKinetics Corp. CRKN shares rose 153% to $0.3325 after gaining 14% on Tuesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share.
  • Vallon Pharmaceuticals, Inc. VLON shares jumped 140% to $0.6041 after the company entered into a definitive merger agreement with GRI Bio.
  • Immix Biopharma, Inc. IMMX jumped 46% to $2.1695 after the company announced it has in-licensed BCMA-targeted next-generation CAR-T therapy NXC-201 with 85% ORR and 71% CR/sCR at the therapeutic dose from the first 20 patients in an ongoing phase 1b relapsed/refractory multiple myeloma ongoing clinical trial.
  • Senti Biosciences, Inc. SNTI rose 45% to $2.09 after dipping more than 21% on Tuesday.
  • Avidity Biosciences, Inc. RNA shares climbed 44.3% to $15.84 after the company announced AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial demonstrating the first-ever successful targeted delivery of RNA into muscle.
  • BIMI International Medical, Inc. BIMI gained 28.1% to $2.6649. BIMI reported entry into a material definitive agreement for the acquisition of Wuzhou Qiangsheng Hospital Co., Ltd., Suzhou Eurasia Hospital Co., Ltd. and Yunan Yuxi Minkang Hospital Co., Ltd.
  • Wave Life Sciences Ltd. WVE gained 21.1% to $5.80. SVB Leerink maintained WAVE Life Sciences with a Market Perform and raised the price target from $2 to $7.
  • Kymera Therapeutics, Inc. KYMR shares gained 21.4% to $31.38 after the company announced results from the Phase 1 clinical trial evaluating KT-474 in patients with HS and AD and Sanofi's decision to advance KT-474 into Phase 2 clinical trials.
  • Aspen Group, Inc. ASPU gained 17.4% to $0.41 after reporting strong quarterly sales.
  • REV Group, Inc. REVG jumped 17.2% to $15.57 as the company reported a fourth-quarter FY22 sales growth of 5.7% year-over-year to $623.6 million, beating the consensus of $595 million.
  • Nuvve Holding Corp. NVVE gained 16.9% to $0.7477.
  • Meiwu Technology Company Limited WNW jumped 16.3% to $2.14.
  • United Insurance Holdings Corp. UIHC jumped 16.2% to $0.5578.
  • Dyne Therapeutics, Inc. DYN jumped 14.7% to $14.00.
  • Sio Gene Therapies Inc. SIOX gained 14.7% to $0.3537.
  • Otonomy, Inc. OTIC jumped 14.4% to $0.1399.
  • Harmonic Inc. HLIT gained 12.9% to $14.86
  • Happiness Development Group Limited HAPP rose 12.9% to $3.9973after surging over 10% on Tuesday.
  • Carvana Co. CVNA gained 12.8% to $5.45.
  • Appreciate Holdings, Inc. SFR jumped 12.4% to $1.90.
  • Harrow Health, Inc. HROW surged 11.9% to $12.43. Harrow Health entered a binding agreement to acquire the exclusive U.S. commercial rights to five FDA‑approved ophthalmic products from Novartis.
  • Mullen Automotive, Inc. MULN jumped 10% to $0.2354. Mullen Automotive partnered with Loop Global to deploy EV charging solutions, including public DC fast charging network and residential offerings.
  • QualTek Services Inc. QTEK gained 9.3% to $0.5463.
  • Cytokinetics, Incorporated CYTK jumped 7.6% to $41.27. The FDA's Cardiovascular and Renal Drugs Advisory Committee voted 8-3 against the approval of Cytokinetics heart failure drug, omecamtiv mecarbil.
  • Processa Pharmaceuticals, Inc. PCSA gained 6.3% to $2.02. Processa Pharmaceuticals said PCS12852 successfully improves the clinical symptoms associated with gastroparesis in Phase 2A trial.



  • Drive Shack Inc. DS fell 55.3% to $0.2126. The company announced its intention to voluntarily delist from the NYSE and to deregister its common stock.
  • ZyVersa Therapeutics Inc ZVSA dipped 36.5% to $4.76.
  • Netcapital Inc. NCPL shares dipped 33.3% to $1.47 after the company announced pricing of a public offering.
  • OpGen, Inc. OPGN fell 29.8% to $0.1621. OpGen shares jumped around 85% on Tuesday after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
  • Puhui Wealth Investment Management Co., Ltd. PHCF fell 25.7% to $2.95.
  • Kaspien Holdings Inc. KSPN fell 24.2% to $0.7490 after the company reported a wider Q3 loss.
  • Versus Systems Inc. VS declined 23.1% to $0.5998.
  • SeqLL Inc. SQL dropped 21.7% to $0.3789.
  • Vincerx Pharma, Inc. VINC declined 21.7% to $0.83.
  • Avadel Pharmaceuticals plc AVDL fell 20.9% to $6.52.
  • Getaround, Inc. GETR fell 20.4% to $1.09.
  • Bit Brother Limited BTB dropped 20% to $0.4238 after the company announced a 1-for-15 reverse share split.
  • Oriental Culture Holding LTD OCG declined 18.8% to $0.71.
  • Yumanity Therapeutics, Inc. YMTX fell 16.8% to $1.6886. Yumanity Therapeutics recently declared a special dividend in connection with the proposed asset sale to Janssen and merger with Kineta.
  • Baudax Bio, Inc. BXRX fell 16.6% to $2.5925.
  • Summit Therapeutics Inc. SMMT fell 16.4% to $3.2691.
  • Bright Health Group, Inc. BHG dropped 16% to $0.6137. Goldman Sachs, on Tuesday, downgraded Bright Health from Neutral to Sell.
  • Arqit Quantum Inc. ARQQ fell 14.7% to $5.33 after the company reported FY22 results and filed for a mixed shelf of up to $100 million..
  • Charter Communications, Inc. CHTR fell 13.3% to $340.65 after it communicated an increase in 2023 capital expenditures at its analyst day held on Tuesday.
  • Rubicon Technology, Inc. RBCN shares fell 13.1% to $1.5814. Rubicon Technology announced voluntary delisting from the Nasdaq.
  • Nexalin Technology, Inc. NXL fell 11.1% to $1.7250.
  • Dragonfly Energy Holdings Corp. DFLI dropped 11% to $12.32.
  • LAVA Therapeutics N.V. LVTX fell 9.4% to $4.20. LAVA Therapeutics announced updated data from the Phase 1/2a clinical trial of LAVA-051 at the 64th American Society of Hematology Annual Meeting and Exposition.
  • Panbela Therapeutics, Inc. PBLA fell 7.1% to $0.1327 after gaining around 53% on Tuesday. Panbela received EMA opinion on orphan designation for Ivospemin in combination with Gemcitabine and nab-paclitaxel in patients with metastatic pancreatic ductal adenocarcinoma.


Also check this out Bitcoin Tops $18,000; GMX, Dogecoin Among Top Losers.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!